Systems Biology Opens New Research Pathways
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Point-of-care (POC) tests are leading to an observable diagnostics market shift. The worldwide market for POC testing is valued at $15–17 billion with a 10% annual growth rate. (For more on POC testing, click here.)